<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H8D576F3BC3A14D15A172C4F70720B09A" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 6231 IH: Ensuring Access to COVID-19 Preventive Care Act of 2020</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2020-03-12</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">116th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 6231</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20200312">March 12, 2020</action-date><action-desc><sponsor name-id="B001275">Mr. Bucshon</sponsor> (for himself and <cosponsor name-id="S001145">Ms. Schakowsky</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To ensure affordable coverage of certain vaccines and testing services under group health plans and group and individual health insurance coverage during the COVID-19 public health emergency.</official-title></form><legis-body id="H5C2BB252A51745A992290986C41CA4D2" style="OLC"><section id="H56B4690B79C44E469021F8D4D6B1C829" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Ensuring Access to COVID-19 Preventive Care Act of 2020</short-title></quote>.</text></section><section id="H8C33A0731E654AB08BDA47FA30218634"><enum>2.</enum><header>Ensuring affordable coverage of certain vaccines and testing services under group health plans and group and individual health insurance coverage during the COVID-19 public health emergency</header><subsection id="HBF08979AFBDF47649BBBDD52FBF48D40"><enum>(a)</enum><header>Expedited meeting of ACIP for COVID-19 vaccines</header><paragraph id="HF5E1718D33B6412E8F841CD2CD822410"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Notwithstanding section 3091 of the 21st Century Cures Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-4">21 U.S.C. 360bbb–4</external-xref> note), the Advisory Committee on Immunization Practices shall meet and issue a recommendation with respect to a vaccine that is intended to prevent or treat COVID-19 not later than 15 business days after the date on which such vaccine is licensed under section 351 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/262">42 U.S.C. 262</external-xref>).</text></paragraph><paragraph id="H504B1F9DA25E4A36815C5B8808E8396C"><enum>(2)</enum><header>Definition</header><text>In this subsection, the term <quote>Advisory Committee on Immunization Practices</quote> means the Advisory Committee on Immunization Practices established by the Secretary of Health and Human Services pursuant to section 222 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/217a">42 U.S.C. 217a</external-xref>), acting through the Director of the Centers for Disease Control and Prevention.</text></paragraph></subsection><subsection id="H4886AEE1CBE745AEAA015BC99EB8BD2C"><enum>(b)</enum><header>Authority To waive cost sharing for testing services for COVID-19</header><text>Section 2713 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300gg-13">42 U.S.C. 300gg–13</external-xref>) is amended—</text><paragraph id="H0DF001C91F4D476897573284CDB9489B"><enum>(1)</enum><text>in the header, by inserting before the period at the end the following: <quote><header-in-text level="section" style="OLC">; coverage of certain testing services for COVID-19</header-in-text></quote>; and</text></paragraph><paragraph id="H64CE53F86D894AD6A5157277D1530619"><enum>(2)</enum><text>by adding at the end the following new subsection:</text><quoted-block style="OLC" id="H3B67134725F649E5B6971468D549A275" display-inline="no-display-inline"><subsection id="H36FB0A6F22BB4EA0829DB0CF5FDB9C9E"><enum>(d)</enum><header>Coverage of certain testing services for COVID-19</header><paragraph id="H146AEC22A9CA48DC94292E9B11D8BC8A"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">A group health plan, and a health insurance issuer offering group or individual health insurance coverage, shall, during a period described in paragraph (2), at a minimum provide coverage for and not impose any cost sharing requirements for an item or service specified by the Secretary under paragraph (3) with respect to such period.</text></paragraph><paragraph id="H2C8F7F59D1CD4280B118048EAB2F630B"><enum>(2)</enum><header>Period described</header><text>For purposes of this subsection and with respect to an item or service specified under paragraph (3) and a group health plan or group or individual health insurance coverage, a period described in this paragraph is a period specified by the Secretary that—</text><subparagraph id="H1708779C95924ADCABF5F0DA58533093"><enum>(A)</enum><text display-inline="yes-display-inline">begins during the public health emergency declared by the Secretary pursuant to section 319 on January 31, 2020, entitled <quote>Determination that a Public Health Emergency Exists Nationwide as the Result of the 2019 Novel Coronavirus</quote> (or any renewal of such declaration pursuant to such section); and</text></subparagraph><subparagraph id="HE4C400EEB2C44F8AB578086C010B28C2"><enum>(B)</enum><text>ends on the earlier of—</text><clause id="H262DF3C0B5A844E292FCA14B87DADFDD"><enum>(i)</enum><text>the termination of such declaration; and</text></clause><clause id="HDE4E8A3F4D474AC99178157D50F92074"><enum>(ii)</enum><text>in the case the United States Preventive Services Task Force issues a rating (other than <quote>I</quote>) with respect to such item or service—</text><subclause id="H70AF7422E5BD4C579E6F640A13660A7C"><enum>(I)</enum><text display-inline="yes-display-inline">in the case such rating is an <quote>A</quote> or <quote>B</quote>, the day before the date on which the requirements of subsection (a) apply to such plan or coverage with respect to such item or service; or</text></subclause><subclause id="H82349988FAED42EBA9BC4D0084E1A114"><enum>(II)</enum><text>in the case such rating is not described in subclause (I), the date such rating is so issued. </text></subclause></clause></subparagraph></paragraph><paragraph id="H888107F1C4CA40EAA736BED16581AC0D"><enum>(3)</enum><header>Specified items and services</header><text>For purposes of this subsection, the Secretary may specify an item or service under this paragraph with respect to a period described in paragraph (2) only if such item or service—</text><subparagraph id="HA2FB15C8E0D0471FAAF76DD710D7EF44"><enum>(A)</enum><text>is a testing service intended to detect SARS–CoV–2 or diagnose COVID-19; and</text></subparagraph><subparagraph id="H7F27C3FD94EC407AB8383E00868F7CC4"><enum>(B)</enum><text>does not, as of the date such item or service is so specified, have in effect a rating from the United States Preventive Services Task Force (or has in effect a rating of <quote>I</quote>).</text></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection></section></legis-body></bill> 

